Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

1997 Vol. 15, No. 2

Cover
Display Method:
1997, (2): 67-69.
Abstract(2287) PDF (2315KB)(1433)
Abstract:
Immunomodulation effect of Iycium barbarum polysaccharide
Song Bingsheng, Yang Yulong
1997, (2): 69-72.
Abstract:
Lyeium barbarum polysaccharide (LBP) is a biological active substance from lyciumbarbarum.It has widely immunostimulation effects including promotillg the function of T, B,CTL, NK and Mφ immunocytes; promoting the formation of IL-2, IL-3 and TNFβ cytokines; en-hancing immnnological function of tumor-bearing and irradiation damage mice and modulatingNIM network, The recent progress in research of immunomodulation effects of LBP was reviewedin this paper.
1997, (2): 72-74.
Abstract:
Clinical observation of effect of leifengshi mixture for rheumatoid arthritis
Zhang Weixing, Luan Xiaochen
1997, (2): 75-76.
Abstract:
Leifengshi mixtures were orally given to 360 patients with rheumatoid arthritis.Itseffect was compared with that of control group (240 cases) treated by non-steroidal antiinflamma-tory and common threewingnut.As a result, the total effective rates of two groups are 91.3%and 34.3%, respectively, with a significant difference (P<0.01).Leifengshi mixtures havemore obviusly curative effects in improvenment of functional disorder and physicochemical indexand in the recovery of immune function.
1997, (2): 77-78.
Abstract:
1997, (2): 78-79.
Abstract:
1997, (2): 79-81.
Abstract:
1997, (2): 82-83.
Abstract:
1997, (2): 83-84.
Abstract:
Compatible stability of compound injection of salviae miltiorrhiza, Vitamin B6 and Vitamin C
Sun Chengchun, Chen Dongmei, Cao Xiaozhi, Wang Jingxiang
1997, (2): 85-87.
Abstract:
Compatible stability of compound injection of salviae miltiorrhim, Vitamin B6 and Vitamin C were observed.The results showed that the compound injection of salviae miltiorrhiza and Vitamin B6 were could compatible in 4 hours, but couldn't compatible with injection of Vitamin C.
1997, (2): 87-88.
Abstract(2061) PDF (880KB)(383)
Abstract:
1997, (2): 88-90.
Abstract:
Adsorb fibrinolysin and profibrinolysin with L-Lysine-Sepharose 4B
Wang Qizhong, Li Xihe, Xu Guanfen, Pang Guangli
1997, (2): 90-92.
Abstract(2242) PDF (2288KB)(1101)
Abstract:
To increase stability and to solve the problem of splitting of human secrum γ-globulin products, we were used to adsorb fibrinolysin and profibrinolysin with L-Lysine-Sepharose 4B.The Result shows that fibrinolysin and profibrinolysin in the human secrum γ-globulin products are adsorpted.Compared with the unadsorbed products, the splitting degree ofthe adsorbed products was decreased obviosly.In manufacture production of human secrum γ-globulin products, adsorbing fibrinolysin and profibrinolysin with L-Lysine-sepharose 4B mayincrease stability of human secrum γ-globulin and solve splitting problem of the product.It is aeffective method to improv the production quality.
1997, (2): 93-93,128.
Abstract:
HPLC determination of caffeine metabolites in urine
Yi Tao, Lu Jianfen
1997, (2): 94-99.
Abstract:
A HPLC method was developed for determination of caffeine metabolites in urine(AFMU, 1X, 1U, 17X, 17U).The samplb added ammonium sulfate was extracted twice by a mixture of chloroform-isopropanol(85:15 vol/vol)and evaporated to dryness with a gentle stream ofair below)25℃.HPLC analysis was carried out on Shim Pack C18 column with methanol-ace-tonitrile-0.05% acetic acid (10:1:89 vol/vol) as the mobile phase and UV detection at 280nm.The assay procedure has been applied to determining urinary metabolites excreted after oral caffeine in a healthy sample(n = 120).Caffeine metabolite ratios were used to assess the poymorphicN-acetyltransferase and CYP1A2 activities.
1997, (2): 99-100.
Abstract:
1997, (2): 100-101.
Abstract:
1997, (2): 102-102.
Abstract:
1997, (2): 103-103.
Abstract(1908) PDF (841KB)(358)
Abstract:
1997, (2): 103-104.
Abstract:
1997, (2): 104-105.
Abstract:
1997, (2): 106-110.
Abstract:
1997, (2): 110-114.
Abstract:
1997, (2): 114-116.
Abstract:
1997, (2): 116-117.
Abstract(1849) PDF (824KB)(299)
Abstract:
1997, (2): 117-120.
Abstract:
1997, (2): 120-122.
Abstract:
1997, (2): 122-125.
Abstract:
1997, (2): 125-127.
Abstract:
1997, (2): 127-128.
Abstract: